March Today, just 1 in 5,000 experimental compounds proves safe and effective enough to reach patients. For new drugs, the road to hospitals and clinics is steep and long. Researchers screen countless promising compounds, but they choose only a few to begin clinical trials. Of those selected, roughly 9 out of 10 will fail. For that […]
lupus
Groundbreaker
Election to the National Academy of Medicine is but the latest first for Dr. Judith James Dr. Judith James can’t remember not wanting to be a doctor. As a 5-year-old, James, who had severe asthma, shared her career intentions with her pediatrician. “He said if I wanted to become a nurse, he would be happy […]
OMRF receives $480,000 to study genetic drivers of lupus
Research will target specific regions of DNA strands to understand role of genetic variants
OMRF to lead nationwide partnership studying autoimmune and immune-mediated diseases
The NIH has selected OMRF to lead a $58.5 million public-private partnership aimed at developing more effective treatments for autoimmune diseases.
New England Journal of Medicine publishes lupus drug trial paper authored by OMRF expert
Clinical trial results illustrate incremental advances in lupus research.
OMRF’s lupus cohort marks 20 years
Tens of thousands of patient samples have contributed to worldwide research.
